ATPace™, a novel injectable formulation of adenosine 5′-triphosphate (ATP), is developed by Cordex Pharma, Inc. (Cordex) as a diagnostic and therapeutic drug for the management of cardiac bradyarrhythmias. Extracellular ATP exerts multiple effects in various cell types by activating cell-surface receptors known as P2 receptors.

Adenosine is a chemical found in human cells. There are three different forms: adenosine, adenosine monophosphate (AMP), and adenosine triphosphate (ATP). Adenosine blocks electrical...

Adenosine phosphate is given by injection into the muscle (intramuscularly) for treating varicose veins, bursitis, pain and swollen tendons (tendonitis), itchiness, multiple sclerosis (MS), neuropathy, shingles (herpes zoster infection), cold sores and genital herpes (herpes simplex infections), and poor blood circulation.

Adenosine is a medication that can bring your heart back to a normal rhythm. It’s an injection that a healthcare provider will give you in a hospital or clinic setting. Brand names of adenosine are Adenocard® and Adenoscan®.

ADENOSINE TRIPHOSPHATE的用量、作用機轉、副作用、懷孕及哺乳用藥與藥物交互作用，ADENOSINE TRIPHOSPHATE適應症:心衰竭、心肌炎、心肌梗塞、動脈硬化。

Adenocard® (adenosine injection) is a sterile, nonpyrogenic solution for rapid bolus intravenous injection. Each mL contains 3 mg adenosine and 9 mg sodium chloride in Water for...

2005年6月13日 · Adenosine triphosphate (ATP) is the nucleotide known in biochemistry as the "molecular currency" of intracellular energy transfer; that is, ATP is able to store and transport chemical energy within cells. ATP also plays an important role in the synthesis of nucleic acids. The total quantity of ATP in the human body is about 0.1 mole.

2011年11月6日 · ATPace™, a novel injectable formulation of adenosine 5′-triphosphate (ATP), is developed by Cordex Pharma, Inc. (Cordex) as a diagnostic and therapeutic drug for the management of cardiac bradyarrhythmias. Extracellular ATP exerts multiple effects in various cell types by activating cell-surface receptors known as P2 receptors.

ATPace™, an injectable formulation of adenosine 5′-triphosphate (ATP), was developed by Cordex Pharma, Inc. (Cordex) as a diagnostic and therapeutic drug for the management of cardiac bradyarrhythmias. Extracellular ATP exerts multiple effects in various cell types by activating cell-surface receptors known as P2 receptors.

This review summarizes clinical application of adenosine and adenosine 5'-triphosphate (ATP) in pain conditions. Investigations have been performed in patients with acute perioperative pain or chronic neuropathic pain treated with intravenous adenosine or ATP, or intrathecal adenosine.